PHASE-I CLINICAL-STUDY OF ECTEINASCIDIN-743 (ET-743) AS A 24 HOURS CONTINUOUS INTRAVENOUS-INFUSION (CI) IN PATIENTS (PTS) WITH SOLID TUMORS(ST) - A PROGRESS REPORT

Authors
TAAMMA A CVITKOVIC E JIMENO J GASPARETTO M MEELEY K VEGA E CAMERON L MISSET JL
Citation
A. Taamma et al., PHASE-I CLINICAL-STUDY OF ECTEINASCIDIN-743 (ET-743) AS A 24 HOURS CONTINUOUS INTRAVENOUS-INFUSION (CI) IN PATIENTS (PTS) WITH SOLID TUMORS(ST) - A PROGRESS REPORT, European journal of cancer, 33, 1997, pp. 1119-1119
Citations number
NO
Categorie Soggetti
Oncology
Journal title
European journal of cancer → ACNP
ISSN journal
09598049
Volume
33
Year of publication
1997
Supplement
8
Pages
1119 - 1119
Database
ISI
SICI code
0959-8049(1997)33:<1119:PCOE(A>2.0.ZU;2-D